Ozempic Lawsuit

Currently, most of the people who have filed Ozempic lawsuits did so because they suffered severe stomach side effects, such as gastroparesis, ileus or intestinal blockage.

However, emerging lawsuits claim the drug caused an eye condition called non-arteritic anterior ischemic optic neuropathy (NAION).

The lawsuits are based on the fact that the manufacturer, Novo Nordisk, knew or should have known that Ozempic could lead to these severe side effects but didn’t warn people about the risks.

Since the FDA approved Ozempic in 2017, the drug’s manufacturer, Novo Nordisk, has not included warnings that the medication can cause gastroparesis in its prescription information. The company has warned about other Ozempic side effects.

In September 2023, the FDA added an Ozempic warning for ileus. Ileus is a condition that causes the intestines to stop working properly. In January 2025, a warning for severe gastrointestinal adverse reactions was added.

While there is no mention of NAION specifically, the label cautions that “vision changes” are a potential serious side effect and highlights concerns about diabetic retinopathy.

There is no cure for NAION or gastroparesis. Plaintiffs are seeking compensation for loss of quality of life, past and future medical bills, and other damages.

Ozempic (semaglutide) belongs to a class of drugs called GLP-1 agonists, and lawyers are also investigating other drugs in this class.

If you were diagnosed with NAION or gastroparesis after using Ozempic or another GLP-1 drug, you may qualify for a lawsuit.

Lawyers are investigating Ozempic vision loss and blindness lawsuits. A 2024 study published in JAMA Ophthalmology reported that patients with Type 2 diabetes who took semaglutide-containing medications had more than a fourfold higher risk for developing non-arteritic anterior ischemic optic neuropathy (NAION) compared with patients not on a GLP-1 agonist.

Overweight people who took semaglutide for weight loss had a more than sevenfold higher risk.

Another 2024 study, involving more than 400,000 patients in the Netherlands, found that people with Type 2 diabetes who used semaglutide had more than double the risk of developing NAION compared to those who didn’t take the drug.

While the FDA has yet to require a warning for NAION on Ozempic and other semaglutide labels, there has been international action on the link.

In June 2025, the World Health Organization (WHO) warned that semaglutide drugs, such as Ozempic, Wegovy and Rybelsus, may rarely cause NAION. The WHO advises patients to seek medical care immediately if they notice rapid changes in their eyesight. It also recommended that doctors should discontinue treatment if NAION is confirmed.

Just weeks before the WHO decision, the European Medicines Agency — the European Union’s counterpart to the FDA — found that NAION is a very rare side effect of semaglutide medicines. Approximately 1 in 10,000 users of drugs like Ozempic, Wegovy and Rybelsus may be affected.

In addition, a 2024 study found that people taking another GLP-1 drug, liraglutide, had a 179% higher risk of developing NAION. This has led to Victoza and Saxenda lawsuits. Both contain liraglutide as their active ingredient.

NAION occurs when blood flow to the optic nerve stops. Researchers think that GLP-1 drugs could affect blood flow to the optic nerve, leading to the development of the eye condition.

To file an Ozempic vision loss lawsuit, you will need to be diagnosed with NAION. The condition is usually diagnosed through a doctor’s exam and patient history, especially if risk factors and typical symptoms are present. Extra tests are only needed if signs are unusual or suggest another eye problem. Doctors focus on ruling out conditions that mimic NAION, since some are more dangerous and require urgent treatment.

It’s essential to save these medical records and reports if you plan to file an Ozempic lawsuit.

Injuries Named in Ozempic Stomach Paralysis Lawsuits

One of the main injuries claimed in the Ozempic lawsuits is gastroparesis (paralyzed stomach).

Gastroparesis is a severe disorder that causes food to move too slowly through the stomach to the small intestine. In some cases, food may stop moving altogether, causing nausea, stomach pain and vomiting.

In addition to gastroparesis, lawyers are investigating cases of ileus, intestinal obstruction or pseudo-obstruction, and other gastrointestinal injuries. Chronic vomiting is one of the main signs of gastroparesis, and some people who filed lawsuits experienced persistent vomiting after taking Ozempic.

It’s important to note that not everyone who takes semaglutide will develop severe side effects.

“The most common side effects would be GI side effects. Nausea, vomiting, a feeling of fullness. Maybe some reflux, like regurgitation, like you taste your food a little bit after you eat,” said Dr. Sue Decotiis, a medical weight loss physician who often prescribes semaglutide and tirzepatide on her medically supervised program.

Do not stop taking Ozempic or any other medication without first consulting your physician. You should talk to your doctor if you experience specific symptoms that could be signs of a severe gastrointestinal injury.

You may qualify to file an Ozempic lawsuit if you took Ozempic for weight loss or any other indication and experienced gastroparesis. Lawyers are currently accepting cases from people who suffered severe gastroparesis resulting in vomiting for four weeks or more.

You may not qualify if you have had gastric bypass surgery, gastric banding or gastric sleeve surgery before taking Ozempic. Additionally, lawyers are not taking Ozempic cases for those being treated for cancer.

These criteria are guidelines, and only an Ozempic lawyer can tell you if you qualify to file a lawsuit. Fill out our free case review form to explore your legal options.

If you want to file an Ozempic lawsuit, there are a few steps to follow. Drugwatch can help you with the process.

Many lawyers work on a “contingency fee” basis, which means you only pay them if they win your case. In the first 30 days, your lawyer will collect your medical records, determine if you have a strong case and provide guidance on what to do next.

Meanwhile, report your injuries to the U.S. Food and Drug Administration’s MedWatch program, which tracks medical injuries from medications.

You Have a Limited Time To File an Ozempic Lawsuit

If you’re considering an Ozempic lawsuit, it’s crucial to understand the statute of limitations. This law dictates how long you have to file a case after being injured. It may be as little as one year, depending on your state.

If you miss this deadline, you could lose your chance for compensation.

Since each state has different rules, it’s wise to check your state’s laws or consult a lawyer to ensure you understand your deadlines and protect your rights.

An Attorney Can Help You Gather Evidence for Your Case

An Ozempic attorney can help you gather information that can help determine if you have a case.

We are still waiting to hear if Ozempic NAION lawsuits will be consolidated in a New Jersey multicounty litigation (MCL).

After the period for public comments closed on Aug. 29, the Administrative Director of the New Jersey Courts was required to submit the application and the feedback to the New Jersey Supreme Court. The court is reviewing all the information to determine whether to establish a special legal process for cases related to Ozempic. If the court decides to move forward, it will assign a judge to oversee the cases and announce this decision publicly.

As of October 2025, there are 2,809 personal injury lawsuits for gastroparesis, ileus and intestinal obstruction in MDL 3094 in the Eastern District of Pennsylvania. Federal judge Karen S. Marston is presiding over the MDL.

Payouts will vary, but lawyers representing plaintiffs in the Ozempic litigation typically estimate a settlement payout of $400,000 to $700,000.

Remember that these estimates are speculative. On the lower end, we are seeing some estimates in the $250,000 range. But other lawyers have suggested that the individual payout amount could be as high as $1 million.

Settlements in Ozempic lawsuits may vary because each plaintiff’s compensation depends on the individual facts of their case.

At this time, no global settlement for the Ozempic lawsuit has been announced by plaintiffs or defendants. There have been no trials so far either. The litigation is still largely in the early stages, but the MDL and individual lawsuits continue to progress.